Skip to main content
Contact Us
Subscribe
E-Edition
51°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ainos Inc
(NQ:
AIMD
)
0.4249
-0.0131 (-2.99%)
Streaming Delayed Price
Updated: 2:00 PM EST, Dec 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ainos Inc
< Previous
1
2
3
4
5
6
7
Next >
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 18, 2023
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic...
Via
Benzinga
Why Arcutis Biotherapeutics Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
December 18, 2023
Shares of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose sharply in pre-market trading after the FDA approved company’s ZORYVE topical foam, 0.3% for the treatment of seborrheic dermatitis in...
Via
Benzinga
Exposures
Product Safety
AIMD Stock Earnings: Ainos Reported Results for Q1 2023
December 14, 2023
Ainos just reported results for the first quarter of 2023.
Via
InvestorPlace
AIMD Stock Earnings: Ainos Reported Results for Q2 2023
December 14, 2023
Ainos just reported results for the second quarter of 2023.
Via
InvestorPlace
AIMD Stock Earnings: Ainos Reported Results for Q3 2023
December 14, 2023
Ainos just reported results for the third quarter of 2023.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
December 18, 2023
It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning!
Via
InvestorPlace
Ainos, Inc. Announces Stock Consolidation
December 12, 2023
Via
ACCESSWIRE
Ainos Announces Successful Manufacturing of VELDONA GMP Clinical Batch by Swiss Pharmaceutical
November 28, 2023
Via
ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 22, 2023
Pre-market stock movers are a hot topic on Wednesday as we check out all of the biggest movements happening this morning!
Via
InvestorPlace
Ainos Reports Third Quarter 2023 Financial Results
November 09, 2023
Via
ACCESSWIRE
Ainos Announces Placement of Initial $3 Million Tranche of $10 Million Private Placement
September 25, 2023
Via
ACCESSWIRE
Ainos Commences Shipping its VELDONA Pet Cytoprotein Supplements in Taiwan
September 05, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 21, 2023
Via
Benzinga
Ainos Announces Positive Data Reported from its Clinical Studies for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA
November 21, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Intraday Session
September 21, 2023
Via
Benzinga
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
September 21, 2023
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday.
Via
Benzinga
Ainos Reports Second Quarter 2023 Financial Results
August 11, 2023
Via
ACCESSWIRE
With Orphan Drug Designation, Ainos' VELDONA Has Compelling Opportunity to Improve Quality of Life for HIV Patients
September 19, 2023
Boston, Massachusetts--(Newsfile Corp. - September 19, 2023) - The U.S. Food and Drug Administration (FDA) has granted Ainos' (NASDAQ:...
Via
Newsfile
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 18, 2023
Via
Benzinga
Ainos’ VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive Patients
September 18, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
September 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 30, 2023
Via
Benzinga
Ainos Celebrates First Listing Anniversary on Nasdaq
August 10, 2023
Via
ACCESSWIRE
Ainos, Inc - The AI Nose "Knows" What's Inside Your Body and Beyond
August 15, 2023
Boston, Massachusetts--(Newsfile Corp. - August 15, 2023) - Here at Horizon Insights, we see...
Via
Newsfile
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ainos Partners with Nisshinbo Micro Devices and Inabata to Co-Develop VOC Sensing Platform For Broader Industry Adoption
August 09, 2023
Via
ACCESSWIRE
7 Healthcare Stocks to Ditch Before They Make Your Portfolio Sick
July 31, 2023
For investors who choose wisely, profits in healthcare stocks can be spectacular. But the losses can also be dramatic if you choose poorly.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 21, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 21, 2023
It's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
July 14, 2023
Via
Benzinga
Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 14, 2023
Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.